Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1990-9-12
|
pubmed:abstractText |
From April 1983 to April 1988, 381 botulinum toxin injections for lid spasms were administered to 106 patients. Sixty-nine had bilateral blepharospasm and 37 had hemifacial spasm. Of the 381 injections, 308 had been given to patients who returned for follow-up examinations. No systemic effects were noted at any of these visits; all side effects were temporary; there were no serious complications. Ptosis, the most frequently encountered problem, occurred after 26 (8.4%) of the injections. Other complications included: corneal exposure (after eight injections, 2.59%); face droop (after 11 injections, 3.57%); diplopia (after five injections, 1.62%); and subtle visual blurring (after eight injections, 2.59%). One patient noted jaw tenseness, another mentioned tearing, one reported brow droop, and another complained of crossed eyes. Ten injections had minimal effect; in these cases a repeat injection usually was effective. Only four patients chose surgery after beginning injections. We conclude that botulinum toxin injections are a safe, effective means of treating lid spasms.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0022-023X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
335-8
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2381655-Adolescent,
pubmed-meshheading:2381655-Blepharoptosis,
pubmed-meshheading:2381655-Blepharospasm,
pubmed-meshheading:2381655-Botulinum Toxins,
pubmed-meshheading:2381655-Diplopia,
pubmed-meshheading:2381655-Dry Eye Syndromes,
pubmed-meshheading:2381655-Eyelid Diseases,
pubmed-meshheading:2381655-Facial Muscles,
pubmed-meshheading:2381655-Female,
pubmed-meshheading:2381655-Humans,
pubmed-meshheading:2381655-Male,
pubmed-meshheading:2381655-Prognosis,
pubmed-meshheading:2381655-Spasm,
pubmed-meshheading:2381655-Vision Disorders
|
pubmed:year |
1990
|
pubmed:articleTitle |
Side effects of the use of botulinum toxin for treatment of benign essential blepharospasm and hemifacial spasm.
|
pubmed:affiliation |
Northeastern Ohio Universities College of Medicine, Canton.
|
pubmed:publicationType |
Journal Article
|